Inventor · disambiguated record
Emiliano Castiglioni
Also filed as: CASTIGLIONI EMILIANO
3 granted patents·5 pending applications·10 citations·filing 2004–2012
57Inventor score
Technology areasA61P
Files withALVARO GIUSEPPE2GLAXO GROUP LTD2CASTIGLIONI EMILIANO1GLAXO WELLCOME MFG PTE LTD1NERRE THERAPEUTICS LTD1
Top patents by PatentIndex Score
8 records- 0182US8133908B2Heteroaryl derivatives of N-{[(1S,4S,6S)-3-(2-pyridinylcarbonyl)-3-azabicyclo[4.1.0]hept-4-yl]methyl}-2-amineALVARO GIUSEPPE·Filed 2009·Granted Mar 13, 2012·10 cites·16 claims
- 0257US8367692B2Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethyl phenyl) methylcarboxamides as NK1 tachikynin receptor antagonistsGLAXO WELLCOME MFG PTE LTD·Filed 2009·Granted Feb 5, 2013·0 cites·13 claims
- 0351US2011172255A1Condensed N-Heterocyclic Compounds and their Use as CRF Receptor AntagonistsSB PHARMCO INC·Filed 2007·Application pending·0 cites
- 0449US8633214B2Spiro (piperidine-4,2′-pyrrolidine)-1-(3,5-trifluoromethylphenyl) methylcarboxamides as NK1 tachikynin receptor antagonistsNERRE THERAPEUTICS LTD·Filed 2012·Granted Jan 21, 2014·0 cites·6 claims
- 0549US2010144760A1Novel compoundsALVARO GIUSEPPE·Filed 2009·Application pending·0 cites
- 0646US2010311734A1Spiro Compounds Useful as Antagonists of the H1 ReceptorGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 0745US2010190764A1Novel compoundsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 0841US2007066640A1Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonistsCASTIGLIONI EMILIANO·Filed 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emiliano Castiglioni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →